Sanofi Q3 2018 Performance Confirms Return to Growth

With the performance we delivered in the third-quarter, Sanofi has returned to growth. We have delivered on our promise to shareholders, while bringing important new medicines and treatments to patients around the world

Olivier Brandicourt
Chief Executive Officer

Third Quarter 2018 Results Infographic